Deal overview

Deal overview
Target ALLERGAN PLC
Bidder ABBVIE INC
Price £90.00 Full version or £25.00 Light version
Publication Date Jun 25, 2019
Abstract On 25 June 2019, the US-based pharmaceutical company AbbVie Inc ("AbbVie") announced that it had agreed to acquire Allergan plc ("Allergan"), an Irish company listed on the New York Stock Exchange, through a scheme of arrangement. The cash and stock transaction valued each Allergan share at $188.24 and represented an equity value of approximately $63 billion. It was expected ...
Number of pages (Full version) 9
Number of pages (Light version) 2
Format Adobe Acrobat (Download Acrobat Reader)
Free Sample Click Here to Download

Purchase this report

Accepted credit cards: Visa, America Express, Master Card

Buy and download this report in a fast a safe way using our secure payment system. We accept all major credit cards.

Search for Deals

Search over 70 million deal reports on more than 550,000 public and private companies. (copy)

Back to search results

Page Time: 0.044005s